Physician profile
Mark E Ryzewicz
NPI 1225184997
$14,221.77
in general payments reported to CMS, 2019-2025
23 companies · $4,585 in 2025
The $4,585 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,407 · 2020: $353 · 2021: $267 · 2022: $3,081 · 2023: $72.74 · 2024: $2,457 · 2025: $4,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,149 · Food and Beverage: $1,717 · Consulting Fee: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,148.83 |
| Food and Beverage | $1,717.17 |
| Consulting Fee | $1,248.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shalby Advanced Technologies, INC. | $4,874.16 | 2024-2025 | Consensus Hip System, Cs2 Acet. Cup Sys. - Vitalite, Acetabular Shell |
| Microport Orthopedics INC | $2,940.98 | 2021-2022 | |
| Arthrex, INC. | $2,782.01 | 2019-2024 | |
| Gemini Mountain Medical, LLC | $2,035.35 | 2019-2024 | |
| Hikma Pharmaceuticals USA | $423.20 | 2024 | Combogesic IV |
| Medacta USA, INC. | $209.36 | 2020-2022 | |
| Smith+Nephew, INC. | $199.55 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $117.90 | 2021-2025 | Breztri |
| Shoulder Innovations, INC. | $97.16 | 2025 | Inset System |
| Amgen INC. | $80.38 | 2019-2022 | |
| Novo Nordisk INC | $76.02 | 2020-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $63.74 | 2019-2023 | Verquvo, Belsomra, Januvia |
| Restor3d, INC. | $58.21 | 2025 | |
| Lilly USA, LLC | $55.00 | 2020-2025 | Zepbound, Mounjaro |
| Biogennix, LLC | $51.91 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abanza INC. | $32.76 | 2025 | Washercap Fixation System 10mm, Washercap Mini Fixation System 4.5mm |
| Stryker Corporation | $30.20 | 2021 | |
| Janssen Pharmaceuticals, INC | $21.97 | 2019 | |
| Orthofix Medical, INC. | $18.67 | 2025 | Physio-Stim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.99 | 2022 | |
| Eisai INC. | $15.17 | 2021 | |
| Nabriva Therapeutics, Plc | $13.07 | 2022 | |
| Organogenesis INC. | $7.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ryzewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.